Literature DB >> 17699790

Involvement of disulfide bond formation in the activation of heparanase.

Siro Simizu1, Takehiro Suzuki, Makoto Muroi, Ngit Shin Lai, Satoshi Takagi, Naoshi Dohmae, Hiroyuki Osada.   

Abstract

Heparanase is overexpressed in many solid tumor cells and is capable of specifically cleaving heparan sulfate, and this activity is associated with the metastatic potential of tumor cells; however, the activation mechanism of heparanase has remained unknown. In this study, we investigated the link between disulfide bond formation and the activation of heparanase in human tumor cells. Mass spectrometry analysis of heparanase purified from a conditioned medium of human fibrosarcoma cells revealed two disulfide bonds, Cys127-Cys179 and Cys437-Cys542, and one S-cysteinylation at the Cys211 residue. It was shown that, although the formation of the Cys127-Cys179 bond and S-cysteinylation at Cys211 have little effect on heparanase function, the disulfide bond between Cys437 and Cys542 is necessary for the secretion and activation of heparanase. Thus, the present findings will provide a basis for the further refinement of heparanase structural studies and for the development of novel heparanase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699790     DOI: 10.1158/0008-5472.CAN-07-1053

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  The intersection of protein disulfide isomerase and cancer associated thrombosis.

Authors:  Jack D Stopa; Jeffrey I Zwicker
Journal:  Thromb Res       Date:  2018-04       Impact factor: 3.944

2.  Dpy-19 like 3-mediated C-mannosylation and expression levels of RPE-spondin in human tumor cell lines.

Authors:  Shohei Morishita; Takehiro Suzuki; Yuki Niwa; Naoshi Dohmae; Siro Simizu
Journal:  Oncol Lett       Date:  2017-06-22       Impact factor: 2.967

Review 3.  Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Ilana Dowek; Ralph D Sanderson; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

4.  Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.

Authors:  Mubashir Hassan; Muhammad Yasir; Saba Shahzadi; Andrzej Kloczkowski
Journal:  ACS Omega       Date:  2022-06-01

5.  Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment.

Authors:  Ghada Abboud-Jarrous; Ruth Atzmon; Tamar Peretz; Carmela Palermo; Bedrick B Gadea; Johanna A Joyce; Israel Vlodavsky
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

Review 6.  Heparanase: busy at the cell surface.

Authors:  Liat Fux; Neta Ilan; Ralph D Sanderson; Israel Vlodavsky
Journal:  Trends Biochem Sci       Date:  2009-09-03       Impact factor: 13.807

7.  Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications.

Authors:  Israel Vlodavsky; Michael Elkin; Neta Ilan
Journal:  Rambam Maimonides Med J       Date:  2011-01-31

Review 8.  Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.

Authors:  Israel Vlodavsky; Uri Barash; Hien M Nguyen; Shi-Ming Yang; Neta Ilan
Journal:  Semin Thromb Hemost       Date:  2021-04-01       Impact factor: 6.398

9.  N-Glycosylation of extracellular matrix protein 1 (ECM1) regulates its secretion, which is unrelated to lipoid proteinosis.

Authors:  Shiho Uematsu; Yuki Goto; Takehiro Suzuki; Yukiko Sasazawa; Naoshi Dohmae; Siro Simizu
Journal:  FEBS Open Bio       Date:  2014-10-12       Impact factor: 2.693

10.  Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure.

Authors:  Kenta Ko; Takehiro Suzuki; Ryota Ishikawa; Natsuko Hattori; Risako Ito; Kenta Umehara; Tomomi Furihata; Naoshi Dohmae; Robert J Linhardt; Kazuei Igarashi; Toshihiko Toida; Kyohei Higashi
Journal:  J Biol Chem       Date:  2020-10-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.